The DOI matches its Crossref record.
Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis
Abstract
Although extensive resources go to cancer care, national population-based data on the costs of such care at the patient level have been unavailable. Medicare payments subsequent to diagnosis of cancer for elderly enrollees with five common cancers were estimated using tumor registry data from the Surveillance, Epidemiology, and End Results Program linked to Medicare claims from 1984 to 1990. The time between diagnosis and death was divided into four phases corresponding to the clinical course of solid tumors, average payments for each phase were estimated (including payments for services not related to cancer), then phase-specific payment data were aggregated. Average payments by phase varied among cancer sites, especially in the initial care phase, where payments were highest for lung and colorectal cancers ($17,500 in 1990 dollars) and lowest for female breast cancer ($8,913). Total Medicare payments from diagnosis to death were highest for persons with bladder cancer ($57,629) and lowest for those with lung cancer ($29,184). Low payments for persons with lung cancer corresponded to brief survival times. Persons diagnosed at earlier stages incurred higher total payments between diagnosis and death than those diagnosed at later stages, reflecting their longer survival. This implies that early detection may increase total Medicare expenditures by extending beneficiaries' lives. However, Medicare payments per year of survival were lower for earlier stages. Data on Medicare payments subsequent to diagnosis of cancer are useful for identifying the cost implications of differences in treatment patterns by demographic characteristics, geography, and delivery systems; comparing the financial impact of alternative therapies; evaluating the long-term cost impacts of screening and prevention programs; and risk-adjusting payments to health plans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research
Yabroff, K. R., Lund, J., Kepka, D., & Mariotto, A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0650 · Cited by 503
The Burden of Illness of Cancer: Economic Cost and Quality of Life
Brown, M. L., Lipscomb, J., & Snyder, C. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.91 · Cited by 309
Time costs associated with informal caregiving for cancer survivors
Yabroff, K. R., & Kim, Y. (2009) · Cancer · doi:10.1002/cncr.24588 · Cited by 303
Nielsen, M. E., Smith, A. B., Meyer, A., Kuo, T., Tyree, S., Kim, W. Y., Milowsky, M. I., Pruthi, R. S., & Millikan, R. C. (2014) · Cancer · doi:10.1002/cncr.28397 · Cited by 149
Breast Cancer Management: Quality-of-Life and Cost Considerations
Radice, D., & Redaelli, A. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321060-00003 · Cited by 146
Metadata
- Authors
- Riley, G. F., Potosky, A. L., Lubitz, J. D., & Kessler, L. G.
- Venue
- Medical Care
- Published
- 1995-08
- Volume
- 33
- Issue
- 8
- Pages
- 828-841
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2094459583
- Cited by
- 332
- References
- 0
- FWCI
- 16.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis. https://app.cochat.ai/papers/10.1097/00005650-199508000-00007
- The paper
- Riley, G. F., Potosky, A. L., Lubitz, J. D., & Kessler, L. G. (1995). Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis. Medical Care. https://doi.org/10.1097/00005650-199508000-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.